Case Study: SOPHiA GENETICS streamlines its first international clinical study with Greenlight Guru Clinical

SOPHiA GENETICS Navigates First International Clinical Study with Greenlight Guru

SOPHiA GENETICS, an AI-powered platform founded in 2011 and headquartered in Switzerland, needed a secure, flexible way to run its first internally managed international multicentric study, DEEP-Lung-IV. The team had to standardize data collection across 30 sites in eight countries for about 4,000 patients while working with complex real-world data from medical records. To meet those needs, they chose Greenlight Guru Clinical, including its eCRF capabilities.

With Greenlight Guru, SOPHiA GENETICS was able to manage the study internally with greater control, responsiveness, and collaboration than larger vendors offered. Greenlight Guru provided the flexibility needed for a highly customized study while also meeting important compliance and security requirements, including ISO 14155:2020 alignment and data protection safeguards. The result was a smoother launch and execution of DEEP-Lung-IV, helping SOPHiA GENETICS confidently handle thousands of participants across multiple countries.

SOPHiA GENETICS

Barbara Chazot

Senior Clinical Operations Specialist